Concepedia

Huafei Lu

HL

3

Publications

45

Citations

3

H-Index

2017

Active since

Affiliations

Johnson & Johnson (Singapore)(Current)

Peking University Third Hospital

Peking University

Huafei Lu is an author at Johnson & Johnson (Singapore).

Publications per year

2017–2018

3

Publications

3

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence

Tianmei Si, Nan Li, Huafei Lu et al. · Journal of Psychopharmacology · 2018 · 18 citations · Full text

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Jingping Zhao, Lehua Li, Jianguo Shi et al. · Neuropsychiatric Disease and Treatment · 2017 · 14 citations · Full text

Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics

Nan Li, Yu Feng, Huafei Lu et al. · Neuropsychiatric Disease and Treatment · 2018 · 13 citations · Full text

Rows per page

1–3 of 3